Wed, Apr 23, 2014, 10:15 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Alnylam Pharmaceuticals, Inc. Message Board

  • techmgr2001 techmgr2001 Oct 8, 2004 3:26 PM Flag

    analyst coverage

    I see that alny has 2 analysts already. How does an analyst truly cover a company in preclinical development? Have they a new crystal ball regarding the outcome of experiments not yet done? At least one of them was neutral, but one outperform? Outperform what - their experiments will work better than others experiments?

    RNAi looks promising. However, developing a profitable product is a long hard road as I and my colleagues in biotech are aware. Making it through clinical trials to market is a long way off in the future.

    In the chemical industry the saw is "test tubes to tank cars = ten years". Biotech is longer still - how about "cell culture to syringes = seventeen years".

 
ALNY
54.32-4.02(-6.89%)Apr 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Apple Inc.
NasdaqGSWed, Apr 23, 2014 4:00 PM EDT
GW Pharmaceuticals plc
NasdaqGMWed, Apr 23, 2014 4:00 PM EDT
Facebook, Inc.
NasdaqGSWed, Apr 23, 2014 4:00 PM EDT